Diagnostic agents for pancreatic exocrine function
OwnerTadashi Kohno, Isaburo Hosoi +3inventors
InventorsTadashi Kohno, Isaburo Hosoi, Junko Ohshima, Kunihiko Shibata, Asuka Ito
Life of this patent
Estimating the term…
Loading patent…
OwnerTadashi Kohno, Isaburo Hosoi +3inventors
InventorsTadashi Kohno, Isaburo Hosoi, Junko Ohshima, Kunihiko Shibata, Asuka Ito
Estimating the term…
The present invention provides a 13C-labeled oligosaccharide or polysaccharide or a salt thereof excluding U-13C-maltose, 13C-starch, 1-13C-maltotetraose and 1-13C-amylose; a derivative of the 13C-labeled oligosaccharide or polysaccharide or salt thereof; a 13C-labeled inclusion complex or a salt thereof, which comprises a cyclodextrin or a modified derivative thereof as a host molecule; a 13C- or 14C-labeled fluorescein ester compound or a salt thereof; and a diagnostic agents for pancreatic exocrine function comprising these compounds 13C- or 14C-labeled.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled
(canceled)
(canceled).
(canceled)
(canceled)
(canceled).
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method of diagnosing pancreatic exocrine function comprising administering a 13C- or 14C-labeled inclusion complex or a salt thereof having a cyclodextrin or a modified derivative thereof as a host molecule.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.